Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GPR55 – a putative “type 3” cannabinoid receptor in inflammation
Hye-Won Yang, Juan Zhou, Christine Lehmann
Journal of Basic and Clinical Physiology and Pharmacology (2015) Vol. 27, Iss. 3, pp. 297-302
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
Stefania Petrosino, Vincenzo Di Marzo
British Journal of Pharmacology (2016) Vol. 174, Iss. 11, pp. 1349-1365
Open Access | Times Cited: 274
Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues
Michael Delacher, Charles D. Imbusch, Dieter Weichenhan, et al.
Nature Immunology (2017) Vol. 18, Iss. 10, pp. 1160-1172
Open Access | Times Cited: 227
Advances in the Physiology of GPR55 in the Central Nervous System
Bruno A. Marichal‐Cancino, Alfonso Fajardo-Valdez, Alejandra E. Ruíz-Contreras, et al.
Current Neuropharmacology (2016) Vol. 15, Iss. 5
Open Access | Times Cited: 115
Cannabinoid signaling in health and disease
Yan Lu, H. D. Anderson
Canadian Journal of Physiology and Pharmacology (2017) Vol. 95, Iss. 4, pp. 311-327
Open Access | Times Cited: 91
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Elise Wouters, Jolien Walraed, Samuel D. Banister, et al.
Biochemical Pharmacology (2019) Vol. 169, pp. 113623-113623
Closed Access | Times Cited: 79
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Dingya Sun, Xin Li, Shengdan Nie, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113993-113993
Open Access | Times Cited: 63
Cannabis Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain
Giuseppina Crescente, Giuseppe Minervini, Carmela Spagnuolo, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 106-106
Open Access | Times Cited: 48
Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease
Sarah Beggiato, Maria Cristina Tomasini, Luca Ferraro
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 72
Therapeutic applications of cannabinoids
Nancy Maurya, Bharath Kumar Velmurugan
Chemico-Biological Interactions (2018) Vol. 293, pp. 77-88
Closed Access | Times Cited: 69
Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells
Soraya Wilke Saliba, Hannah Jauch, Brahim Gargouri, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 66
GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues
Christopher Lipina, Sarah K. Walsh, Sharon E. Mitchell, et al.
The FASEB Journal (2018) Vol. 33, Iss. 1, pp. 1299-1312
Open Access | Times Cited: 61
A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity
Katrina Hurst, Corinne Badgley, Tanner Ellsworth, et al.
Hippocampus (2017) Vol. 27, Iss. 9, pp. 985-998
Open Access | Times Cited: 53
A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment
Bola Tayo, Lesley Taylor, Farhad Sahebkar, et al.
Clinical Pharmacokinetics (2019) Vol. 59, Iss. 6, pp. 747-755
Open Access | Times Cited: 48
Ultramicronized N-palmitoylethanolamine associated with analgesics: Effects against persistent pain
Stefania Nobili, Laura Micheli, Elena Lucarini, et al.
Pharmacology & Therapeutics (2024) Vol. 258, pp. 108649-108649
Open Access | Times Cited: 4
Utilization of Cannabidiol in Post-Organ-Transplant Care
Sachiko Koyama, Jumar Etkins, Jin-Sun Jun, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 699-699
Open Access
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
Siyuan Shen, Chao Wu, Zhiqian Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Structural basis for lipid-mediated activation of G protein-coupled receptor GPR55
Tobias Claff, R. Ebenhoch, Jörg T. Kley, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Polyunsaturated fatty acids and their endocannabinoid-related metabolites activity at human TRPV1 and TRPA1 ion channels expressed in HEK-293 cells
Atnaf Alebie Abate, Marina Santiago, Alfonso E. Garcia‐Bennett, et al.
PeerJ (2025) Vol. 13, pp. e19125-e19125
Open Access
Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing
Cecilia P. Kramar, Michaël Loureiro, Justine Renard, et al.
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 8-20
Open Access | Times Cited: 44
Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases
Cristina Prandi, Marco Blangetti, Dvora Namdar, et al.
Molecules (2018) Vol. 23, Iss. 7, pp. 1526-1526
Open Access | Times Cited: 42
Medical cannabis: Another piece in the mosaic of autoimmunity?
D. Katz, I. Katz, BS Porat‐Katz, et al.
Clinical Pharmacology & Therapeutics (2016) Vol. 101, Iss. 2, pp. 230-238
Closed Access | Times Cited: 39
Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2-GPR55 heteromers
Silvia L. Cruz, Elizabeth Sánchez-Miranda, Jorge Iván Castillo-Arellano, et al.
International Immunopharmacology (2018) Vol. 64, pp. 298-307
Closed Access | Times Cited: 38
Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia
Roberto Chiocchetti, Giorgia Galiazzo, Claudio Tagliavia, et al.
Frontiers in Veterinary Science (2019) Vol. 6
Open Access | Times Cited: 35
The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling
Argelia Calvillo-Robledo, Rodolfo Daniel Cervantes‐Villagrana, Paula Morales, et al.
Life Sciences (2022) Vol. 301, pp. 120596-120596
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top